# Abzena: Moving medicine forward\. > Abzena is a fully integrated biopharmaceutical CDMO\+CRO for antibodies, ADCs, AOCs, RDCs, vaccines, from discovery thru commercial\. Generated by Yoast SEO v28.4, this is an llms.txt file, meant for consumption by LLMs. ## Pages - [Careers](https://abzena.com/careers/) - [Internships](https://abzena.com/careers/internships/) - [Awards \& Achievements](https://abzena.com/about/awards-achievements/) - [Why Abzena?](https://abzena.com/about/why-abzena/) - [Abzena is a fully integrated biologics, bioconjugates \& ADC CDMO \+ CRO](https://abzena.com/cdmo/) ## Services - [Oncology CDMO \+ CRO Development \& Manufacturing Services](https://abzena.com/biologics/oncology-cdmo-cro/): Accelerate your path to market with our advanced, integrated biologics CDMO \+ CRO services \& solutions that move medicine forward\. - [Biologics](https://abzena.com/biologics/): Accelerate your path to market with our advanced, integrated biologics CDMO \+ CRO services \& solutions that move medicine forward\. - [Degrader\-Antibody Conjugates \(DACs\) Development \& Manufacturing](https://abzena.com/biologics/bioconjugates-and-adcs/degrader-antibody-conjugates-dacs/): Discover the leading end\-to\-end DAC CDMO partner from design to development through to manufacturing\. - [Move forward from DNA to IND/CTA faster](https://abzena.com/solutions/integrated-biologics/dna-ind-cta/): Accelerate promising biologic candidates into clinical\-ready therapies through integrated DNA\-to\-IND/CTA programs that reduce risk, shorten timelines, and help bring medicines to patients faster\. - [Antibody\-Oligonucleotide Conjugates \(AOCs\)](https://abzena.com/biologics/bioconjugates-and-adcs/antibody-oligonucleotide-conjugates-aocs/): We are global leaders in the development of antibody\-oligonucleotide conjugates \(AOCs\)\. ## Events - [CPHI Milan 2026](https://abzena.com/event/cphi-milan-2026/) - [TKS: Antibody\-Drug Conjugates Symposium](https://abzena.com/event/tks-antibody-drug-conjugates-symposium/) - [Seattle Multiomics Mixer](https://abzena.com/event/seattle-multiomics-mixer/) - [PEGs Europe 2026](https://abzena.com/event/pegs-europe-2026/) - [Festival of Biologics EU 2026](https://abzena.com/event/festival-of-biologics-eu-2026/) ## Team - [Troy Wright](https://abzena.com/about/leadership-team/troy-wright/) - [Thomas Cornell](https://abzena.com/about/leadership-team/thomas-cornell/) - [Tatyana Touzova](https://abzena.com/about/leadership-team/tatyana-touzova/) - [Campbell Bunce](https://abzena.com/about/leadership-team/campbell-bunce/) - [Peter Gray](https://abzena.com/about/leadership-team/peter-gray/) ## Resources - [B Cell Antibody Discovery \- ANTI\-PD1 Case Study](https://abzena.com/resources/case-studies/b-cell-antibody-discovery-anti-pd1-case-study/) - [Scientific Poster: Application of Real\-Time Live Cell Imaging in the Development of Antibody\-Drug Conjugates](https://abzena.com/resources/scientific-posters-and-publications/application-of-real-time-live-cell-imaging-in-the-development-of-antibody-drug-conjugates/) - [Leveraging Analytics to Ensure Stable \& Scalable Cell Lines](https://abzena.com/resources/webinars-and-videos/leveraging-analytics-to-ensure-stable-scalable-cell-lines/) - [Optimal Formulation Development](https://abzena.com/resources/webinars-and-videos/optimal-formulation-development/) - [Cell Line Development: An Overview of the Linchpin in Successful Biotherapeutic Development](https://abzena.com/resources/whitepapers/an-overview-of-cell-line-development/): Cell Line Development \(CLD\) is the linchpin of biotherapeutic development and manufacturing\. Discover our CLD whitepaper here today\. ## News Articles - [PharmTech: Strategies to Maximize Stability of Emerging Biologics](https://abzena.com/articles/feature-articles/pharmtech-strategies-to-maximize-stability-of-emerging-biologics/) - [Pharma Source: ADCs vs\. AOCs \- Shared Design Principles \& Key Differences in Bioconjugate Engineering](https://abzena.com/articles/feature-articles/pharma-source-adcs-vs-aocs-shared-design-principles-key-differences-in-bioconjugate-engineering/) - [PharmaSource Podcast: Abzena on AOCs \- Building US Capacity to Compete With China](https://abzena.com/articles/feature-articles/pharmasource-podcast-abzena-on-aocs-building-us-capacity-to-compete-with-china/) - [Pharma's Almanac: How are organizations balancing cost with regulatory, supply chain, \& reputational risk when selecting partners or sites?](https://abzena.com/articles/feature-articles/how-are-organizations-balancing-cost-with-regulatory-supply-chain-and-risk-when-selecting-partners/) - [European Pharmaceutical Review: Strategies for scaling complex next\-generation biologics](https://abzena.com/articles/feature-articles/european-pharmaceutical-review-scaling-next-gen-biologics/) ## History - [2023](https://abzena.com/history/2023-2/) - [2022](https://abzena.com/history/2022-2/) - [2013](https://abzena.com/history/2013-2/) - [2025](https://abzena.com/history/2025-2/) - [2024](https://abzena.com/history/2024-2/) ## Facilities - [Cambridge, UK](https://abzena.com/about/locations/cambridge-uk/): Abzena Cambridge specializes in the early discovery, design, and development of complex biologics and bioconjugates\. - [Bristol, PA, USA](https://abzena.com/about/locations/bristol-usa/): At Abzena Bristol, we specialize in bioconjugation, quality linker payloads, highly potent materials and complex chemistry\. - [Raleigh, NC, USA](https://abzena.com/about/locations/raleigh-nc-usa/): At Abzena Bristol, we specialize in bioconjugation, quality linker payloads, highly potent materials and complex chemistry\. - [San Diego, CA, USA](https://abzena.com/about/locations/san-diego-usa/): Abzena San Diego boasts a trio of cutting\-edge facilities designed to accelerate the development, production, and testing of biologics\.  ## Content type - [Webinars \& Videos](https://abzena.com/resources/webinars-and-videos/) - [Scientific Posters \& Publications](https://abzena.com/resources/scientific-posters-and-publications/) - [Info Sheets](https://abzena.com/resources/info-sheets/) - [Case Studies](https://abzena.com/resources/case-studies/) - [Whitepapers](https://abzena.com/resources/whitepapers/) ## Content Type - [Articles](https://abzena.com/articles/feature-articles/) - [News](https://abzena.com/articles/news/) - [Blog](https://abzena.com/articles/blog/) ## Facility Service - [Manufacturing](https://abzena.com/tax-facility-service/manufacturing/) - [Discovery](https://abzena.com/tax-facility-service/discovery/) - [Development](https://abzena.com/tax-facility-service/development/) ## Optional - [Sitemap index](https://abzena.com/sitemap_index.xml)